Old Web
English
Sign In
Acemap
>
authorDetail
>
Eshan Malek
Eshan Malek
Dexamethasone
Refractory Multiple Myeloma
Immunology
Lenalidomide
Oncology
2
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A Phase 1/2 Trial of Low-Dose Continuous Azacitidine in Combination with Lenalidomide and Low-Dose Dexamethasone in Relapsed/Refractory Multiple Myeloma
2019
Clinical Lymphoma, Myeloma & Leukemia
Jack Khouri
Beth Faiman
Wei Wei
Dale Grabowski
Christy Samaras
Reda Z. Mahfouz
Hillard M. Lazarus
Robert M. Dean
Eshan Malek
Janice Reed
Mary Ann Karam
Kimberly Hamilton
Nathaniel Rosko
Sherry Fada
Matt Kalaycio
Hien Liu
Yogen Saunthararajah
Yap Chew
Jason Valent
Frederic J. Reu
Show All
Source
Cite
Save
Citations (0)
Phase 2 Study of Pomalidomide (POM) + Low-Dose Dexamethasone (LoDEX) Following Second-Line Lenalidomide (LEN)-Based Treatment (Tx) in Patients (Pts) With Relapsed or Refractory Multiple Myeloma (RRMM): An Updated Analysis of Efficacy and Safety
2017
Clinical Lymphoma, Myeloma & Leukemia
David Siegel
Gary J. Schiller
Kevin W. Song
Richy Agajanian
Keith Stockerl-Goldstein
Hakan Kaya
Michael Sebag
Frederic J. Reu
Eshan Malek
Jorge Mouro
Weiyuan Chung
Shankar Srinivasan
Max Qian
Syed Rizvi
Anjan Thakurta
Nizar J. Bahlis
Show All
Source
Cite
Save
Citations (0)
1